Strategy Beyond The Bench: Eurofins Launches New U.S. Consulting Chapter In Medtech Strategy & Policy

• Eurofins Medical Device Consulting broadens its impact on client engagement and innovative solutions – turning quality data into actional strategy and insight.
• Eurofins Medical Device Consulting’s most recent investment in meeting the demands of MedTech transcends expertise to support every phase in the product lifecycle.
• Eurofins Medical Device Consulting supports the stakeholder spectrum - from venture capital diligence to premarket submission strategy, and post-market compliance.

Eurofins is pleased to launch Eurofins Medical Device Consulting – the latest investment in supporting critical innovation across MedTech in the U.S.

In launching this key offering, Eurofins Medical Device Consulting marks an inflection point for its Medical Device, Combination Product, and Diagnostic service portfolio – moving from testing services provider to full-lifecycle partner in strategy and insights. Building upon world-class bioanalytical expertise, Eurofins Medical Device Consulting is strategy beyond the bench.

Eurofins Medical Device Consulting launches with a focus on regulatory policy and strategy. Centered in Washington, DC, and connected across the globe – engagement is always local. Our consultant team brings cross-functional experience – leveraging background in regulatory strategy, product development, and government relations to support your product from conceptualization, through FDA authorization and beyond. From investment diligence, commercial strategy, regulatory, quality, and toxicology consulting to human factors engineering – Eurofins’ approach drives scientific solutions, client trust & satisfaction, and patient safety.